Drug profile

The FDA adverse-event record for Insulin (Unknown)

197 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Insulin (Unknown). See the species affected, top reactions, and outcomes below.

197
adverse-event reports
7.1%
death-coded share
Dog
most-reported species
40
Emesis - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
197
Total Reports
14
Deaths Reported
7.1%
Death Rate

Active Ingredients

Insulin (Unknown)

Administration Routes

UnknownParenteralSubcutaneousOralIntravenous

Species Affected

Dog 136
Cat 52
Human 9

Most Affected Breeds

Domestic Shorthair 31
Pug 10
Bichon Frise 10
Pinscher - Miniature 9
Unknown 9
Retriever - Labrador 8
Domestic Mediumhair 7
Schnauzer - Miniature 7
Crossbred Canine/dog 6
Terrier - Yorkshire 6

Most Reported Reactions

Emesis 40
Vomiting 30
Lack of efficacy - NOS 26
Lethargy (see also Central nervous system depression in 'Neurological') 21
Hyperglycaemia 19
Lack of efficacy (ectoparasite) - flea 18
Diarrhoea 16
Weight loss 12
Decreased appetite 11
Death by euthanasia 11
Behavioural disorder NOS 8
Other abnormal test result NOS 8

Outcome Breakdown

Recovered/Normal
73 (37.1%)
Outcome Unknown
57 (28.9%)
Ongoing
27 (13.7%)
Recovered with Sequela
26 (13.2%)
Euthanized
11 (5.6%)
Died
3 (1.5%)

Insulin (Unknown) Adverse Event Insights

197 reports name Insulin (Unknown); 14 recorded a death outcome (7.1% of reported events, not a population-level mortality rate). Active ingredient: Insulin (Unknown). Administration routes: Unknown, Parenteral, Subcutaneous, Oral.

By species: Dog (136 reports), Cat (52 reports), Human (9 reports). By breed: Domestic Shorthair (31), Pug (10), Bichon Frise (10).

Leading clinical signs: Emesis (40), Vomiting (30), Lack of efficacy - NOS (26), Lethargy (see also Central nervous system depression in 'Neurological') (21). Outcome, 197 coded reports: Recovered/Normal leads at 37.1%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.